We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NATI
676
DELISTED
National Instruments Corp
NATI
| $9.29M | 0.02% |
285,456
+5,816
| +2% | +$185K |
|
677
Yum China
YUMC
$15.7B
| $9.28M | 0.02% |
341,225
+4,604
| +1% | +$123K |
|
|
BMS
678
DELISTED
Bemis
BMS
| $9.26M | 0.02% |
189,531
+13,231
| +8% | +$651K |
|
|
HRC
679
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $9.24M | 0.02% |
130,946
+6,016
| +5% | +$383K |
|
|
THS
680
DELISTED
Treehouse Foods
THS
| $9.22M | 0.02% |
108,919
+4,162
| +4% | +$334K |
|
|
SNV
681
DELISTED
Synovus
SNV
| $9.21M | 0.02% |
224,637
+9,589
| +4% | +$400K |
|
|
GRMN
682
Garmin
GRMN
$56.9B
| $9.21M | 0.02% |
180,228
+6,319
| +4% | +$318K |
|
683
Emcor
EME
$29.9B
| $9.2M | 0.02% |
146,096
+6,434
| +5% | +$427K |
|
684
Gaming and Leisure Properties
GLPI
$13B
| $9.18M | 0.02% |
274,748
+20,221
| +8% | +$638K |
|
|
TGNA
685
DELISTED
TEGNA Inc
TGNA
| $9.15M | 0.02% |
558,352
+21,154
| +4% | +$325K |
|
686
Cullen/Frost Bankers
CFR
$10.5B
| $9.13M | 0.02% |
102,645
+4,240
| +4% | +$381K |
|
|
ARRS
687
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $9.11M | 0.02% |
344,356
+13,634
| +4% | +$381K |
|
688
NewMarket
NEU
$7.24B
| $9.09M | 0.02% |
20,063
+4,187
| +26% | +$1.83M |
|
689
Royal Gold
RGLD
$16.6B
| $9.09M | 0.02% |
129,756
+5,344
| +4% | +$362K |
|
690
DexCom
DXCM
$29B
| $9.07M | 0.02% |
428,068
+12,632
| +3% | +$247K |
|
|
WGL
691
DELISTED
Wgl Holdings
WGL
| $9.06M | 0.02% |
109,774
+5,940
| +6% | +$483K |
|
|
DCT
692
DELISTED
DCT Industrial Trust Inc.
DCT
| $9.05M | 0.02% |
188,057
+13,186
| +8% | +$621K |
|
693
Carter's
CRI
$1.43B
| $9.03M | 0.02% |
100,511
+3,468
| +4% | +$299K |
|
694
Middleby
MIDD
$6.01B
| $9.02M | 0.02% |
66,074
+2,312
| +4% | +$314K |
|
695
Fair Isaac
FICO
$31.8B
| $9M | 0.02% |
69,760
+2,363
| +4% | +$300K |
|
696
Charles River Laboratories
CRL
$11.3B
| $8.96M | 0.02% |
99,661
+3,150
| +3% | +$268K |
|
697
WEX
WEX
$6.42B
| $8.9M | 0.02% |
86,025
+2,354
| +3% | +$261K |
|
698
TripAdvisor
TRIP
$1.7B
| $8.9M | 0.02% |
206,211
+1,324
| +0.6% | +$62.8K |
|
699
Signet Jewelers
SIG
$3.84B
| $8.87M | 0.02% |
128,083
+517
| +0.4% | +$38.7K |
|
700
HF Sinclair
DINO
$16.2B
| $8.85M | 0.02% |
312,211
+13,561
| +5% | +$396K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.